BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24008850)

  • 1. Adherence to antiretroviral therapy among HIV-infected prisoners.
    Paparizos V; Kourkounti S; Leuow K; Georgoulas S; Kyriakis K; Antoniou C
    Infez Med; 2013 Sep; 21(3):189-93. PubMed ID: 24008850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis.
    Uthman OA; Oladimeji O; Nduka C
    AIDS Care; 2017 Apr; 29(4):489-497. PubMed ID: 27582186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?
    Nellen JF; Nieuwkerk PT; Burger DM; Wibaut M; Gras LA; Prins JM
    AIDS Care; 2009 Jul; 21(7):842-50. PubMed ID: 20024740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral treatment in correctional facilities.
    Pontali E
    HIV Clin Trials; 2005; 6(1):25-37. PubMed ID: 15765308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to Antiretroviral Therapy Adherence in One of the Prisons in Iran.
    Farhoudi B; Seyedalinaghi S; Jafarinasab M; Ghavam SM; Dadras O; Alipour A; Alijani M
    Infect Disord Drug Targets; 2020; 20(6):848-853. PubMed ID: 31729304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV outcomes at a Canadian remand centre.
    Subramanian Y; Khan MN; Berger S; Foisy M; Singh A; Woods D; Pyne D; Ahmed R
    Int J Prison Health; 2016 Sep; 12(3):145-56. PubMed ID: 27548017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups.
    Dworkin MS; Douglas GW; Sabitha Rani GP; Chakraborty A
    Int J STD AIDS; 2016 Mar; 27(3):186-95. PubMed ID: 25801316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An audit of HIV care in English prisons.
    Chan SY; Marsh K; Lau R; Pakianathan M; Hughes G
    Int J STD AIDS; 2015 Jun; 26(7):504-8. PubMed ID: 25080291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Medication Attitudes on Utilization of Antiretroviral Therapy (ART) in Indonesian Prisons.
    Culbert GJ; Bazazi AR; Waluyo A; Murni A; Muchransyah AP; Iriyanti M; Finnahari ; Polonsky M; Levy J; Altice FL
    AIDS Behav; 2016 May; 20(5):1026-38. PubMed ID: 26400080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Namibian prisoners describe barriers to HIV antiretroviral therapy adherence.
    Shalihu N; Pretorius L; van Dyk A; Vander Stoep A; Hagopian A
    AIDS Care; 2014; 26(8):968-75. PubMed ID: 24499371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence.
    Wang EA; McGinnis KA; Long JB; Akgün KM; Edelman EJ; Rimland D; Wang KH; Justice AC; Fiellin DA
    Am J Addict; 2015 Mar; 24(2):178-184. PubMed ID: 25662297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain).
    Soto Blanco JM; Pérez IR; March JC
    Int J STD AIDS; 2005 Feb; 16(2):133-8. PubMed ID: 15807941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam.
    Cuong do D; Thorson A; Sönnerborg A; Hoa NP; Chuc NT; Phuc HD; Larsson M
    Scand J Infect Dis; 2012 Mar; 44(3):201-8. PubMed ID: 22122590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia.
    Azmeraw D; Wasie B
    Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiretroviral therapy in inmates: between guidelines and reality of Italian correctional facilities].
    Ranieri R; Sommella J; D'Angelo C; Nigro F; Poccobelli M; Lari C; Di Benedetto D; D'Arminio Monforte A
    Infez Med; 2015 Jun; 23(2):148-54. PubMed ID: 26110295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial.
    Wohl DA; Scheyett A; Golin CE; White B; Matuszewski J; Bowling M; Smith P; Duffin F; Rosen D; Kaplan A; Earp J
    AIDS Behav; 2011 Feb; 15(2):356-64. PubMed ID: 21042930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil.
    Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM
    J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to Highly Active Antiretroviral Therapy Among Children in Ethiopia: A Systematic Review and Meta-analysis.
    Endalamaw A; Tezera N; Eshetie S; Ambachew S; Habtewold TD
    AIDS Behav; 2018 Aug; 22(8):2513-2523. PubMed ID: 29761291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long term adherence to HAART in Senegal].
    Bastard M; Fall MB;
    Bull Soc Pathol Exot; 2014 Oct; 107(4):241-3. PubMed ID: 24615434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.